Results 21 to 30 of about 180,250 (243)

Intra-parotid facial nerve schwannoma: case report of a rare entity [PDF]

open access: yes, 2016
Intraparotid facial nerve schwannoma was first reported by Ibarz in 1927. The frequency of intra-parotid schwannomas range from 0.2% to 1.5%. Facial nerve schwannoma can occur at any point along its course from the cerebello-pontine angle to its ...
Kanpurwala, Shaheen H.   +2 more
core   +2 more sources

Facial Nerve Neuroma

open access: yesEar, Nose & Throat Journal, 1972
AbstractFacial nerve neuromas are uncommon, slow growing, and readily treatable when detected. Fourteen patients with facial nerve neuromas are reported here. These tumors can occur within any part of the intratemporal course of the facial nerve. Occurrence and progression of the symptoms depend on the site of origin of the tumor and are those of ...
C, Deguine, J L, Pulec
openaire   +5 more sources

Bilateral Facial Paralysis Caused by Temporal Bone Fracture: A Case Report [PDF]

open access: yes, 2016
Introduction: Although bilateral facial nerve palsy is a rare condition, its etiology is more detectable than the unilateral type. A temporal bone fracture is one cause of bilateral facial nerve palsy, contributing in 3% of the cases.
Banaei, M., Ghiasi, S.
core   +1 more source

Influence of cyclic AMP on facial nerve regeneration in rats [PDF]

open access: yes, 2008
Promoting facial nerve regeneration is a significant challenge. AIM: To evaluate the possible neurotrophic influence of cyclic AMP on facial nerve regeneration of Wistar rats.
Borin, Andrei   +5 more
core   +4 more sources

Meatal Segment of facial nerve and cavernous hemangioma [PDF]

open access: yes, 2014
Cavernous malformations of the internal auditory canal (IAC) are a rare clinical entity. We report a rare case of cavernous hemangioma involving the internal auditory canal and the meatal segment of the facial nerve without any evident lesion to the ...
Iannella, Giannicola, Magliulo, Giuseppe
core  

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

Automatic facial analysis for objective assessment of facial paralysis [PDF]

open access: yes, 2009
Facial Paralysis is a condition causing decreased movement on one side of the face. A quantitative, objective and reliable assessment system would be an invaluable tool for clinicians treating patients with this condition. This paper presents an approach
He, Shu   +3 more
core  

Use of a recombinant pseudorabies virus to analyze motor cortical reorganization after unilateral facial denervation [PDF]

open access: yes, 2005
A unilateral facial nerve injury (n7x) was found to influence the transcallosal spread of the attenuated strain of pseudorabies virus (PRV Bartha) from the affected (left) primary motor cortex (MI) to the contralateral MI of rats.
Boda, Krisztina   +8 more
core   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu   +11 more
wiley   +1 more source

Development of 4T1 breast cancer mouse model system for preclinical carbonic anhydrase IX studies

open access: yesFEBS Open Bio, EarlyView.
Carbonic anhydrase IX (CAIX) is a well‐recognised therapeutic target and prognostic biomarker in cancer. We developed and characterised a robust murine breast cancer model system that is suitable for CAIX studies in vitro and in vivo—it comprises both CAIX‐positive and CAIX‐negative controls and provides a solid platform for the comprehensive ...
Zane Kalniņa   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy